NYSE publicly traded industry selects EPGL's advanced technologies for development

EP Global Communications, Inc., (OTC Ticker EPGL) makes the following announcement:

In a first for the company, one of EPGL's advanced technologies has been selected by a multi-billion dollar, NYSE publicly traded industry leader for development and integration into new products.

The Development Agreement was signed last week, being the week of December 8, 2013.

"This is the biggest development for our company in its history,"  said David T. Markus PhD.  "This is just the first of many possible Agreements to come for EPGL and its advanced technologies.  EPGL is a leader in BioMEMS technology and the companies we develop with will become leaders as well in this field for their particular products."

The two companies have signed a confidentiality agreement due to the sensitive and competitive nature of the technology.  Details of the first Development Agreement will remain confidential for now.  However, PwC as custodian for AJW Funds Board membership of EPGL has been apprised of the Agreement and its details.

EPGL currently has over 15 new advanced technologies and corporations in the medical device and consumer electronics fields have sought to enter relationship with the company.  Because of this development, EPGL intends to expand upon and focus on this business model going forward. 

EPGL Management and Team would like to wish all of our shareholders a Merry Christmas, Happy Hanukkah and Happy New Year.